As of 2026-09-11, the Relative Valuation of Pacira Biosciences Inc (PCRX) is 6.36 USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.36 USD, the upside of Pacira Biosciences Inc based on Relative Valuation is -74.9%.
The range of the Relative Valuation is 4.95 - 8.64 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 14.4x | 13.3x |
| Forward P/E multiples | 13.3x - 19.4x | 17.5x |
| Fair Price | 4.95 - 8.64 | 6.36 |
| Upside | -80.5% - -65.9% | -74.9% |
| Date | P/E |
| 2026-09-11 | 68.41 |
| 2026-09-10 | 67.64 |
| 2026-09-09 | 69.57 |
| 2026-09-08 | 69.54 |
| 2026-09-04 | 70.83 |
| 2026-09-03 | 71.51 |
| 2026-09-02 | 71.45 |
| 2026-09-01 | 71.16 |
| 2026-08-31 | 69.62 |
| 2026-08-28 | 69.25 |
| 2026-08-27 | 69.44 |
| 2026-08-26 | 69.62 |
| 2026-08-25 | 68.63 |
| 2026-08-24 | 66.83 |
| 2026-08-21 | 66.32 |
| 2026-08-20 | 64.06 |
| 2026-08-19 | 65.48 |
| 2026-08-18 | 64.52 |
| 2026-08-17 | 62.47 |
| 2026-08-14 | 61.83 |
| 2026-08-13 | 62.31 |
| 2026-08-12 | 63.71 |
| 2026-08-11 | 65.54 |
| 2026-08-10 | 65.67 |
| 2026-08-07 | 67.26 |
| 2026-08-06 | 68.76 |
| 2026-08-05 | 66.86 |
| 2026-08-04 | 74.25 |
| 2026-08-03 | 72.37 |
| 2026-07-31 | 71.00 |
| 2026-07-30 | 72.50 |
| 2026-07-29 | 70.97 |
| 2026-07-28 | 72.07 |
| 2026-07-27 | 71.16 |
| 2026-07-24 | 69.57 |
| 2026-07-23 | 69.71 |
| 2026-07-22 | 68.79 |
| 2026-07-21 | 69.30 |
| 2026-07-20 | 68.15 |
| 2026-07-17 | 68.85 |
| 2026-07-16 | 68.82 |
| 2026-07-15 | 68.09 |
| 2026-07-14 | 67.23 |
| 2026-07-13 | 68.66 |
| 2026-07-10 | 68.50 |
| 2026-07-09 | 68.55 |
| 2026-07-08 | 68.60 |
| 2026-07-07 | 69.41 |
| 2026-07-06 | 68.79 |
| 2026-07-02 | 68.25 |